Medicare Programs - End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment (US Centers for Medicare and Medicaid Services Regulation) (CMS) (2018 Edition)

Medicare Programs – End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment (US Centers for Medicare and Medicaid Services Regulation) (CMS) (2018 Edition)

The Law Library presents the complete text of the Medicare Programs – End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment (US Centers for Medicare and Medicaid Services Regulation) (CMS) (2018 Edition).Updated as of May 29, 2018 This rule updates and makes revisions to the End-Stage Renal Disease (ESRD) prospective payment […]

Black Lung Benefits Act - Disclosure of Medical Information and Payment of Benefits (US Workers Compensation Programs Office Regulation) (WCPO) (2018 Edition)

Black Lung Benefits Act – Disclosure of Medical Information and Payment of Benefits (US Workers Compensation Programs Office Regulation) (WCPO) (2018 Edition)

The Law Library presents the complete text of the Black Lung Benefits Act – Disclosure of Medical Information and Payment of Benefits (US Workers Compensation Programs Office Regulation) (WCPO) (2018 Edition).Updated as of May 29, 2018 This final rule revises the regulations implementing the Black Lung Benefits Act to address certain procedural issues that have […]

Payment of Trial Participants Can Be Ethically Sound: Moving Past a Flat Rate (Opinion)

Payment of Trial Participants Can Be Ethically Sound: Moving Past a Flat Rate (Opinion)

The South African Medicines Control Council (MCC) policy that trial participants be paid a flat rate of R150 per visit in clinical trials has been criticised in the press. (1) The literature argues that it is an excessive or inappropriate reward; (2) it neglects salient factors such as the design or nature of the study, […]